IGF1 and endometrial cancer: For women, IR and hyperinsulinemia lower Sex Hormone-Binding Globulin levels, increasing free sex hormones, while IGF-1 interacts with insulin signaling and hormone receptors, collectively promoting the development of hormone-sensitive tumors in women, such as breast and endometrial cancer [29, 83].